Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solventum (SOLV) Cash & Equivalents (2023 - 2025)

Historic Cash & Equivalents for Solventum (SOLV) over the last 3 years, with Q3 2025 value amounting to $1.6 billion.

  • Solventum's Cash & Equivalents rose 11269.43% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 11269.43%. This contributed to the annual value of $762.0 million for FY2024, which is 29278.35% up from last year.
  • Solventum's Cash & Equivalents amounted to $1.6 billion in Q3 2025, which was up 11269.43% from $492.0 million recorded in Q2 2025.
  • In the past 5 years, Solventum's Cash & Equivalents ranged from a high of $1.6 billion in Q3 2025 and a low of $194.0 million during Q4 2023
  • In the last 3 years, Solventum's Cash & Equivalents had a median value of $767.0 million in 2024 and averaged $786.1 million.
  • As far as peak fluctuations go, Solventum's Cash & Equivalents skyrocketed by 29278.35% in 2024, and later plummeted by 4638.55% in 2025.
  • Over the past 3 years, Solventum's Cash & Equivalents (Quarter) stood at $194.0 million in 2023, then soared by 292.78% to $762.0 million in 2024, then surged by 115.49% to $1.6 billion in 2025.
  • Its Cash & Equivalents stands at $1.6 billion for Q3 2025, versus $492.0 million for Q2 2025 and $534.0 million for Q1 2025.